Thrombotic thrombocytopenic purpura: treatment with nafazatrom.
D015121:6-Ketoprostaglandin F1 alpha / Q000031:analogs & derivatives / Q000097:blood; D000293:Adolescent; D011464:Epoprostenol / Q000097:blood; D005260:Female; D006801:Humans; D011697:Purpura, Thrombotic Thrombocytopenic / Q000097:blood / Q000188:drug therapy*; D011720:Pyrazoles / Q000627:therapeutic use*; D047069:Pyrazolones
D011720:Pyrazoles; D047069:Pyrazolones; D015121:6-Ketoprostaglandin F1 alpha; C033371:6,15-diketo-13,14-dihydroprostaglandin F1alpha; D011464:Epoprostenol; C018845:nafazatrom